Progenics Investor relations Team works to provide, shareholders, analysts and potential investors with timely, relevant and reliable information.
We strive to make our press releases, scientific papers, and abstracts timely and accurate when issued. Subsequent events may affect their continued accuracy beyond the date of issuance and posting on the website. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.